The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, yet its future within the broader industry now triggers questions about potential yields . Copycat versions are eroding exclusivity , leading to worries that betting on companies closely tied to Viagra's once-dominant position could be a problematic str